30 results on '"Koffijberg, H"'
Search Results
2. MSR24 Can Artificial Intelligence Separate the Wheat From the Chaff in Systematic Reviews of Health Economic Papers?
3. HTA142 Potential Impact of Biomarker Guided-Decisions on Overtreatment in Immunotherapy for Non-Small Cell Lung Cancer Patients
4. EE318 Evaluating the Cost Effectiveness of the Towards Home-Based Albuminuria Screening (THOMAS) Study for Early Detection and Treatment of Chronic Kidney Disease
5. EE114 Cost-Utility Analysis of Lung Cancer Screening Combined With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease Screening
6. P22 Value of Information - Consolidated Health Economic Evaluation Reporting Standards: A Checklist Extension
7. EP01.02-001 Citizens’ Perspective on Combination Screening for Lung Cancer, COPD and CVD
8. PCN212 PERSONALIZED DISCRETE EVENT SIMULATION OF PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL FOR FIRST-LINE DOUBLET CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
9. PRM150 - TECHNOLOGY DIFFUSION IN HEALTHCARE: INSIGHTS FROM AN AGENT-BASED SIMULATION
10. PRM144 - AN OVERVIEW OF META-MODELING METHODS TO ADDRESS RUNTIME ISSUES ASSOCIATED WITH ADVANCED ANALYSES OF HEALTH ECONOMIC MODELS
11. PRM125 - SYSTEMATIC REVIEW OF META-MODELING APPLICATIONS AND OPPORTUNITIES FOR ADVANCED ANALYSES WITH HEALTH ECONOMIC MODELS
12. PMD117 - POINT-OF-CARE TESTING IN PRIMARY CARE: A SYSTEMATIC REVIEW OF TEST EVALUATIONS AND AVAILABLE EVIDENCE
13. PMD31 - THE CONCORDANCE AND BUDGET IMPACT OF MULTIPLE ER, PR AND HER2 DETERMINATIONS IN DUTCH BREAST CANCER PATIENTS
14. PRM111 - The Impact Of Cluster Selection Methods In Two-Stage Bootstrapping To Assess Uncertainty In Health Economic Outcomes In Cluster Randomized Controlled Trials
15. PRM146 - From Evaluation To Optimization: Using A Meta-Model To Maximize The Benefits Of Colorectal Screening Accounting For Capacity Constraints
16. PCN106 - Estimating The Drug Treatment Cost of Breast Cancer
17. PCN315 - Physicians’ Behavior Influences the Health and Economic Impact of Applying Circulating Tumor Cells as Response Marker in Metastatic Castration-Resistant Prostate Cancer
18. PRM136 - Reflecting Uncertainty in Early HTA When Evidence on Parameter Distributions is Lacking: A Comparison of Methods
19. PRM110 - A Review on the Current Status of Health Economic Modeling in Personalized Medicine
20. RM8 - Comparison of Timed Automata with Discrete Event Simulation for Modeling Personalized Treatment Decisions: the Case of Metastatic Castration Resistant Prostate Cancer
21. PRM229 - Research Prioritization In An Mcda Context: Existing Methods - New Results
22. PRM98 - HEALTH ECONOMIC EVALUATION OF DIAGNOSTIC AND PROGNOSTIC PREDICTION MODELS. A SYSTEMATIC REVIEW
23. PCV101 - Cost Effectiveness Of Renal Denervation Therapy For The Treatment Of Resistant Hypertension In The Netherlands
24. PCV68 - Screening Strategies for Heart Failure in Patients with Type 2 Diabetes: Assessing Cost-Effectiveness in Those Aged 60 Years or Over
25. PRM65 A Minimal Information Decision-Analytic Approach to Early HTA of Diagnostic Tests
26. PCV78 ANEURYSM OCCLUSION IN ELDERLY PATIENTS WITH ANEURYSMAL SUBARACHNOID HAEMORRHAGE: A COST-UTILITY ANALYSIS
27. PRM113 - Timed Automata Modeling of The Personalized Treatment Decisions In Metastatic Castration Resistant Prostate Cancer
28. PRM93 - Selecting Evidence-Based Preventive Treatment Thresholds By Optimizing Preferred Outcomes
29. PRM82 - Impact of Uncertainty In Predicted Risks on The Cost-Effectiveness of Risk-Stratified Preventive Treatment Strategies
30. PMD23 - Identifying The Optimal Use Of Ctcs In The Early Staging Phase Of Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.